Cargando…

Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma

Renal impairment (RI) is a common clinical presentation in patients with multiple myeloma (MM). Despite treatment with novel agents or management strategies that focus on the disease response, some patients develop irreversible RI. This study aimed to determine the influencing, clinical variables of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Hiroki, Terao, Toshiki, Tsushima, Takafumi, Abe, Yoshiaki, Miura, Daisuke, Narita, Kentaro, Kitadate, Akihiro, Takeuchi, Masami, Matsue, Kosei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300410/ https://www.ncbi.nlm.nih.gov/pubmed/32311841 http://dx.doi.org/10.1002/cam4.3050

Ejemplares similares

Baseline total lesion glycolysis combined with interim positron emission tomography‐computed tomography is a robust predictor of outcome in patients with peripheral T‐cell lymphoma
por: Kitadate, Akihiro, et al.
Publicado: (2020)

N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma
por: Abe, Yoshiaki, et al.
Publicado: (2019)

Multiple myeloma with t(11;14)‐associated immature phenotype has lower CD38 expression and higher BCL2 dependence
por: Kitadate, Akihiro, et al.
Publicado: (2021)

Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach
por: Terao, Toshiki, et al.
Publicado: (2020)

Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
por: Narita, Kentaro, et al.
Publicado: (2021)

Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
por: Tsushima, Takafumi, et al.
Publicado: (2021)

Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years
por: Matsue, Kosei, et al.
Publicado: (2019)

Bone marrow infiltration pattern in patients with intravascular large B‐cell lymphoma diagnosed by random skin biopsy
por: Matsue, Kosei, et al.
Publicado: (2020)

Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma
por: Terao, Toshiki, et al.
Publicado: (2021)

Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society
por: Abe, Yoshiaki, et al.
Publicado: (2019)

Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-Versus-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide
por: Terao, Toshiki, et al.
Publicado: (2021)

Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
por: Tsushima, Takafumi, et al.
Publicado: (2022)

Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma
por: Terao, Toshiki, et al.
Publicado: (2022)

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Antibody response to COVID-19 vaccination in patients with lymphoma
por: Narita, Kentaro, et al.
Publicado: (2022)

Brain toxoplasmosis after HLA haploidentical transplantation for acute myeloid leukemia
por: Tsushima, Takafumi, et al.
Publicado: (2022)

Racial difference in histologic subtype of renal cell carcinoma
por: Olshan, Andrew F, et al.
Publicado: (2013)

Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma
por: Suehara, Yasuhito, et al.
Publicado: (2017)

Renal cell carcinoma risk associated with lower intake of micronutrients
por: Bock, Cathryn H., et al.
Publicado: (2018)

Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis
por: Mitani, Seiichiro, et al.
Publicado: (2019)

Racial disparities in renal cell carcinoma: a single‐payer healthcare experience
por: Mafolasire, Abiodun, et al.
Publicado: (2016)

P1547: CLINICAL CHARACTERISTICS OF PATIENTS WITH PROLONGED VIRAL SHEDDING OF OMICRON VARIANT IN HAEMATOLOGICAL DISEASE
por: Ikeda, Daisuke, et al.
Publicado: (2023)

Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
por: Radocha, Jakub, et al.
Publicado: (2018)

Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial‐ethnic group, United States 2003‐2016
por: Ellington, Taylor D., et al.
Publicado: (2020)

Is there different risk of cancer among end‐stage renal disease patients undergoing hemodialysis and peritoneal dialysis?
por: Lee, Yi‐Che, et al.
Publicado: (2018)

Racial/ethnic disparities in renal cell carcinoma: Increased risk of early‐onset and variation in histologic subtypes
por: Batai, Ken, et al.
Publicado: (2019)

Epidemiology of multiple myeloma in 17 Latin American countries: an update
por: Curado, Maria Paula, et al.
Publicado: (2018)

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma
por: Yang, Man, et al.
Publicado: (2019)

P1137: COMBINED METABOLIC HETEROGENEITY AND TOTAL LESION GLYCOLYSIS FROM PET-CT IMPROVES THE PROGNOSTIC STRATIFICATION IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA
por: Ikeda, Daisuke, et al.
Publicado: (2023)

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
por: McGrath, Leah J., et al.
Publicado: (2018)

The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study
por: Gregersen, Henrik, et al.
Publicado: (2017)

Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study
por: Matsunami, Masatoshi, et al.
Publicado: (2021)

Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma
por: Andronesi, Andreea G., et al.
Publicado: (2019)

Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real‐world evaluation
por: Baker, Hailey A., et al.
Publicado: (2018)

IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan
por: Asai, Daisuke, et al.
Publicado: (2013)

Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study
por: Tokoro, Akihiro, et al.
Publicado: (2019)

Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease
por: Ikeda, Daisuke, et al.
Publicado: (2023)

Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study
por: Vano, Yann‐Alexandre, et al.
Publicado: (2022)

Comparative study of (18)F-FDG-PET/CT imaging and serum hTERT mRNA quantification in cancer diagnosis
por: Ping, Bingqiong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5j4nnmvn8q2tco1rk1bolrcouq